“Lebrikizumab Patients Treated in the Real World: First North American Data from the PPDTM CorEvitasTM AD Registry”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s609. https://doi.org/10.25251/gmn1ta26.